8-KThe WireRoutine
Company Update
Filed Mar 9, 2026 · 3mo ago · Accession 0001664710-26-000024
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 8-K
- Filing date
- Mar 9, 2026
- Report date
- Mar 9, 2026
- Document
- kros-20260309.htm
- Size
- 233 KB